$AXON

Kalinowski Caitlin Elizabeth sold $19K of AXON

Kalinowski Caitlin Elizabeth sold 40 shares of AXON ENTERPRISE, INC. (AXON) at $484.11 on 2026-06-01.

Original reporting
SEC EDGAR · Kalinowski Caitlin Elizabeth
Published Jun 2, 2026, 9:23 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 2, 2026, 9:24 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AXON
Neutral
medium confidence
Mentioned
$AXON
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AXONNeutralLow
01

Why it matters

Insider sales can marginally influence short-term sentiment, but without accompanying guidance, contract, litigation, or operational updates, the trading edge is limited.

02

Market read

Primarily a sentiment/positioning datapoint; not a standalone fundamental catalyst.

03

What to watch

No 10b5-1 plan is stated, but the filing alone does not reveal whether the sale was tax-related, scheduled for personal reasons, or driven by diversification constraints.

Relevance 6/10Novelty 2/10Timing: After-hours/filing update on 2026-06-02 for the 2026-06-01 sale

Background

The article is an SEC Form 4 insider transaction filing for Axon Enterprise, reporting a director’s open-market sale.

Company-level read

Ticker impact

$AXONNeutralMedium confidence
Context

Axon director Caitlin Elizabeth Kalinowski filed an open-market sale of 40 shares at $484.11 on 2026-06-01 (no 10b5-1 plan stated).

Expected impact

Low near-term impact; any reaction is likely limited to sentiment/flow rather than a new catalyst.

Evidence & confidence

The filing provides a specific transaction size and price, but insider selling without a stated catalyst typically has limited predictive power versus earnings, guidance, or deal/regulatory news.

Market effects

None—single-company insider transaction with no sector-wide signal.

None.

None.

Counterpoint

The sale could be routine liquidity/portfolio rebalancing rather than a bearish signal, especially given the small number of shares relative to typical institutional flows.

Key entities

  • AXON ENTERPRISE, INC.

    Company whose director insider sale is disclosed via SEC Form 4.

  • Kalinowski Caitlin Elizabeth

    Director who sold 40 shares at $484.11 on 2026-06-01; holdings after transaction: 3,632 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AXONHighAI 9/10

Axon’s (AXON) Dilution Fears Look Overstated

Axon Enterprise (AXON) stock fell after announcing a $1B convertible-note offering, but analysts argue dilution fears are overstated. The notes carry 0% interest, convert at $652.06, and are hedged to $1,049.94. Q2 revenue rose 35% to $904M, marking 10 straight quarters of over 30% growth. Management raised full-year revenue growth outlook to 32-34%. AXON has a Strong Buy consensus rating, with an average price target of $719.55.

$AXONHighAI 8/10

Why Did Axon Stock Fall Ten Percent On A Convertible That Pays No Interest?

Axon Enterprise (AXON) shares dropped 9.8% after announcing a $1.0 billion convertible note offering with a 0% coupon. The market interpreted this as a sign of cash flow challenges despite strong revenue growth (34.6% YoY). The company cited inventory investments and rising component costs. AXON's stock is now 43% below its 52-week high, trading at 11x trailing revenue with shrinking margins.

$AXONHighAI 9/10

Axon Q2FY26 Results: Revenue rises 35% to $904 million, guidance raised

Axon Enterprise reported Q2FY26 revenue of $904M, up 35% YoY, and raised full-year guidance to 32-34% growth. Software & services revenue rose 36% to $398M, while connected devices revenue grew 35% to $507M. Platform solutions revenue surged 123% to $150M. The company plans a $1B convertible note offering due 2031, with net proceeds for general corporate purposes and capped call transactions. Shares were up 0.50% in premarket trading.

$AXONHighAI 8/10

Full Transcript: Axon Enterprise Q2 2026 Earnings Call - (AXON)

Axon Enterprise (AXON) reported a record Q2 2026 with 39% growth, driven by demand for Dedrone, Taser 10, and Axon Body 4. The company raised its full-year revenue guidance to 32-34% growth, citing strong bookings and market expansion. Management highlighted investments in AI and public safety technologies, emphasizing trust and data privacy.

$AXONMedAI 8/10

Axon Rebounded 6% Wednesday. Here’s What Could Drive the Stock Through 2026

Axon Enterprise's stock rebounded 6% to $468 on Wednesday after a 10% drop following a $1 billion convertible notes offering. The company expects 32-34% revenue growth in 2026, with strong Q4 growth anticipated. Analysts maintain bullish targets, citing Axon's faster expansion compared to competitors like Motorola Solutions. The stock has an implied upside of 56% based on a valuation model target of $706.